Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth

By R. D, John Wiley, Sons, Ltd, L. E. O F C O N T E N T S. Cochrane Database of Systematic Reviews, 2007

2,718 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. (2021, background): “Do not administer corticosteroids to hasten resolution of HELLP syndrome (⊕⊕⊕O/Strong) Antenatal corticosteroids, in a single course, should be administered to women with HDPs in line with recommendations for any woman at <34+0 weeks who is at risk of birth within the next 7 days, to reduce neonatal”
Glucocorticoid receptor signaling in health and disease (2013, background): “Over the past decade, glucocorticoid therapy has drastically improved the outcome of preterm births by significantly decreasing neonatal mortality and morbidity by accelerating fetal lung maturation and survival in infants born <34 weeks of gestation [74].”
Prenatal Stress, Glucocorticoids and the Programming of Adult Disease (2009, background): “Although these treatments greatly improve survival (Roberts and Dalziel, 2006), they are not without adverse affects.”
Bronchopulmonary Dysplasia: Executive Summary of a Workshop (2018, background): “Antenatal corticosteroid therapy can improve lung maturity and reduce neonatal mortality and complications.(25) Antenatal corticosteroid therapy has been reported to decrease mortality rates in 23- to 25-week gestational age infants; however, survivors have higher rates of BPD.”